Research & Development
Medtronic receives FDA clearance for LigaSure RAS Maryland instrument on Hugo system
16 September 2026 - Healthcare technology company Medtronic (NYSE: MDT) announced on Wednesday that it has received US Food and Drug Administration clearance for its LigaSure RAS Maryland jaw device f...
VaxThera partners with Codagenix for next generation yellow fever vaccine advancement
16 September 2026 - Colombian biotechnology company VaxThera S.A.S. and US-based Codagenix Inc, a clinical-stage biotechnology company focused on synthetic biology-based vaccines, announced on Tuesday...
MaaT Pharma receives negative CHMP trend vote for MaaT013
15 September 2026 - Clinical-stage biotechnology company MaaT Pharma (Euronext Paris:MAAT) disclosed on Tuesday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...
FDA approves Scholar Rock's ISEMBYLD to treat spinal muscular atrophy
15 September 2026 - Cure SMA, a nonprofit organisation supporting those impacted by spinal muscular atrophy (SMA), on Monday welcomed the announcement by biopharmaceutical company Scholar Rock (NASDAQ...
FDA grants priority review to Takeda's zasocitinib application for plaque psoriasis
14 September 2026 - Japanese pharmaceutical company Takeda (TSE:4502) (NYSE:TAK) said on Monday that the US Food and Drug Administration (FDA) has accepted its new drug application for zasocitinib (TA...
Armata Pharmaceuticals announces receipt of FDA Breakthrough Therapy Designation for AP-SA02
14 September 2026 - Biotechnology company Armata Pharmaceuticals Inc (NYSE American: ARMP) reported on Monday that it has received U.S. Food and Drug Administration Breakthrough Therapy designation fo...